TOKYO, Oct. 7, 2025 /PRNewswire/ — Leading Japanese pharmaceutical company Kubota Pharmaceutical Holdings Co., Ltd. will introduce Thailand to its groundbreaking myopia management device, Kubota Glass, at Bangkok.
Addressing Thailand’s Growing Myopia Crisis
Thailand is facing a growing myopia challenge, with studies reporting that over 60%* of young adults are already myopic—among the highest rates observed in Southeast Asia. This pattern reflects the wider regional concern, where nearly half of the world’s population is projected to be myopic by 2050.
“Thai families are increasingly concerned about their children’s vision health, especially with increased screen time from online learning,” said a company spokesperson. “Kubota Glass represents a breakthrough solution that could transform how Thai eye care professionals address childhood myopia.”
Revolutionary Japanese AR Technology
Kubota Glass employs proprietary AR X optical technology developed in Japan, which projects actively stimulated defocus onto the retina to suppress myopia progression. The device requires only two hours of daily wear, making it highly practical for Thai children’s busy schedules while maintaining rigorous safety standards in compliance with ISO 15004-2 for ophthalmic instruments.
Strong Early Clinical Results
Small-scale pilot studies in the United States and Taiwan have shown encouraging preliminary results, including a high responder rate of up to 92%, with ongoing research continuing to evaluate the device’s long-term efficacy and safety profile.
Key Features for Thai Market
- Ultra-lightweight design at just 40g for comfortable daily use
- Smart monitoring capabilities to track usage and treatment compliance
- Non-invasive approach offering an alternative to daily eye drops
- ISO 15004-2 certified safety standards for ophthalmic instruments
- Convenient 2-hour daily wear fitting busy family schedules
Major Opportunity for Thai Eye Care Industry
The Bangkok exhibition will give Thai ophthalmologists, optical shop owners, and optometrists exclusive access to experience this cutting-edge technology firsthand. Early adoption of Kubota Glass represents not only a solution to meet growing patient needs, but also a significant competitive advantage for eye care professionals in Thailand’s rapidly growing optical and ophthalmic markets.
The company is committed to accelerating its expansion throughout Asia through strategic partnerships and comprehensive practitioner support.
|
* Is there an impending epidemic of myopia in Southeast Asia? An appraisal of the evidence |
Building Partnerships Across Thailand
Kubota is exploring opportunities to establish partnerships with Thai optical chains, eye hospitals, and independent practitioners as part of their regional expansion strategy.
About Kubota Pharmaceutical Holdings
Founded in Japan, Kubota Pharmaceutical Holdings and its subsidiary Kubota Vision Inc. specialize in innovative vision care solutions. Under their mission “Innovation for Vision,” the company develops next-generation ophthalmic technologies to improve quality of life worldwide. Thailand represents a key strategic market in their Asian expansion.
Exhibition Details
Event: World Optical Fair Bangkok 2025
Dates: October 9-11, 2025
Venue: IMPACT Exhibition Center, Bangkok
Booth: 6C057
Thai media and eye care professionals are invited for exclusive demonstrations and interviews.
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/japanese-innovation-comes-to-thailand-revolutionary-myopia-management–device-kubota-glass-debuts-at-asean-international-optics-fair-bangkok-2025-302574660.html
SOURCE Kubota Pharmaceutical Holdings Co., Ltd.
